North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Daratumumab
found
7 matches
Open monograph to display formulary status
BNF Category
Daratumumab
(Darzalex
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (Aug 2019): Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus (08.01.05)
NICE TA763: Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable (08.01.05)
NICE TA783: Daratumumab monotherapy for treating relapsed and refractory multiple myeloma (08.01.05)
NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
NICE TA917: Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable (08.01.05)
NICE TA959: Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis (08.01.05)